Pre-analytical variables in miRNA analysis

Clinical Biochemistry

Volumn 46, Issue 10-11, 2013, Pages 861-868

  Becker, Nils ^a   Lockwood, Christina M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circulating; FFPE; MicroRNA; MiRNA; Pre analytical; Tissue; Variables

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

BLOOD CELL COUNT; HEMOLYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICRODISSECTION; PLASMA VOLUME; PRIORITY JOURNAL; REVIEW; RNA EXTRACTION; RNA STABILITY; STORAGE;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84886092843     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.02.015     Document Type: Review

References (96)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene LIN-4 encodes small RNAs with antisense complementarity to LIN-14. Cell 1993, 75:843-854.
2. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529.
3. Michael MZ S.M.O.C., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
4. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
5. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
6. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
7. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
8. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67:6130-6135.
9. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
10. Haybaeck J., Zeller N., Heikenwalder M. The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis. Swiss Med Wkly 2011, 141:w13287.
11. Kuhn D.E., Nuovo G.J., Martin M.M., Malana G.E., Pleister A.P., Jiang J., et al. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun 2008, 370:473-477.
12. Starega-Roslan J., Koscianska E., Kozlowski P., Krzyzosiak W.J. The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci 2011, 68:2859-2871.
13. Bonini P., Plebani M., Ceriotti F., Rubboli F. Errors in laboratory medicine. Clin Chem 2002, 48:691-698.
14. Lippi G., Guidi G.C., Mattiuzzi C., Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006, 44:358-365.
15. Ottomano C. Errors in medicine and errors in laboratory medicine: what is the difference? Blood transfusion=trasfusione del sangue 2010, 8:79-81.
16. Doleshal M., Magotra A.A., Choudhury B., Cannon B.D., Labourier E., Szafranska A.E. Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2008, 10:203-211.
17. Ach R.A., Wang H., Curry B. Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 2008, 8:69.
18. Votavova H., Forsterova K., Stritesky J., Velenska Z., Trneny M. Optimized protocol for gene expression analysis in formalin-fixed, paraffin-embedded tissue using real-time quantitative polymerase chain reaction. Diagn Mol Pathol 2009, 18:176-182.
19. McDonald J.S., Milosevic D., Reddi H.V., Grebe S.K., Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011, 57:833-840.
20. Wang W.X., Rajeev B.W., Baldwin D.A., Isett R.B., Ren N., Stromberg A., et al. Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue. Biochim Biophys Acta 2008, 1779:749-757.
21. Dahlgaard J., Mazin W., Jensen T., Pohl M., Bshara W., Hansen A., et al. Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC). BMC Res Notes 2011, 4:424.
22. Medeiros F., Rigl C.T., Anderson G.G., Becker S.H., Halling K.C. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch Pathol Lab Med 2007, 131:1805-1816.
23. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
24. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011, 108:5003-5008.
25. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011, 39:7223-7233.
26. Garzon R., Pichiorri F., Palumbo T., Visentini M., Aqeilan R., Cimmino A., et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157.
27. Rossi A., D'Urso O.F., Gatto G., Poltronieri P., Ferracin M., Remondelli P., et al. Non-coding RNAs change their expression profile after retinoid induced differentiation of the promyelocytic cell line nb4. BMC Res Notes 2010, 3:24.
28. Wang X., Gocek E., Liu C.G., Studzinski G.P. MicroRNAs181 regulate the expression of p27kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin d3. Cell Cycle 2009, 8:736-741.
29. Peng X., Vaishnav A., Murillo G., Alimirah F., Torres K.E., Mehta R.G. Protection against cellular stress by 25-hydroxyvitamin d3 in breast epithelial cells. J Cell Biochem 2010, 110:1324-1333.
30. Gaedicke S., Zhang X., Schmelzer C., Lou Y., Doering F., Frank J., et al. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett 2008, 582:3542-3546.
31. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res 2006, 66:10843-10848.
32. Sarveswaran S., Liroff J., Zhou Z., Nikitin A.Y., Ghosh J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: implication for the treatment of early-stage prostate cancer. Int J Oncol 2010, 36:1419-1428.
33. Chartoumpekis D.V., Zaravinos A., Ziros P.G., Iskrenova R.P., Psyrogiannis A.I., Kyriazopoulou V.E., et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One 2012, 7:e34872.
34. Arola-Arnal A., Blade C. Proanthocyanidins modulate microRNA expression in human hepg2 cells. PLoS One 2011, 6:e25982.
35. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 2008, 7:464-473.
36. Zhang J., Zhang T., Ti X., Shi J., Wu C., Ren X., et al. Curcumin promotes apoptosis in a549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Commun 2010, 399:1-6.
37. Tili E., Michaille J.J., Alder H., Volinia S., Delmas D., Latruffe N., et al. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in sw480 cells. Biochem Pharmacol 2010, 80:2057-2065.
38. Tili E., Michaille J.J., Adair B., Alder H., Limagne E., Taccioli C., et al. Resveratrol decreases the levels of mir-155 by upregulating mir-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010, 31:1561-1566.
39. Tsang W.P., Kwok T.T. Epigallocatechin gallate up-regulation of mir-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 2010, 21:140-146.
40. Wen X.Y., Wu S.Y., Li Z.Q., Liu Z.Q., Zhang J.J., Wang G.F., et al. Ellagitannin (bja3121), an anti-proliferative natural polyphenol compound, can regulate the expression of miRNAs in hepg2 cancer cells. Phytother Res 2009, 23:778-784.
41. Li Y., VandenBoom T.G., Kong D., Wang Z., Ali S., Philip P.A., et al. Up-regulation of mir-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009, 69:6704-6712.
42. Li Y., Vandenboom T.G., Wang Z., Kong D., Ali S., Philip P.A., et al. Mir-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010, 70:1486-1495.
43. Majid S., Dar A.A., Saini S., Chen Y., Shahryari V., Liu J., et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res 2010, 70:2809-2818.
44. Parker L.P., Taylor D.D., Kesterson J., Metzinger D.S., Gercel-Taylor C. Modulation of microRNA associated with ovarian cancer cells by genistein. Eur J Gynaecol Oncol 2009, 30:616-621.
45. Sun Q., Cong R., Yan H., Gu H., Zeng Y., Liu N., et al. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep 2009, 22:563-567.
46. Radom-Aizik S., Zaldivar F., Leu S.Y., Adams G.R., Oliver S., Cooper D.M. Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin Transl Sci 2012, 5:32-38.
47. Drummond M.J., McCarthy J.J., Fry C.S., Esser K.A., Rasmussen B.B. Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. Am J Physiol Endocrinol Metab 2008, 295:E1333-E1340.
48. Te J.L., Dozmorov I.M., Guthridge J.M., Nguyen K.L., Cavett J.W., Kelly J.A., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5:e10344.
49. Chen F., Zhang W., Liang Y., Huang J., Li K., Green C.D., et al. Transcriptome and network changes in climbers at extreme altitudes. PLoS One 2012, 7:e31645.
50. Yang Q., Qiu C., Yang J., Wu Q., Cui Q. MIRenvironment database: providing a bridge for microRNAs, environmental factors and phenotypes. Bioinformatics 2011, 27:3329-3330.
51. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 2009, 106:2319-2324.
52. Marczylo E.L., Amoako A.A., Konje J.C., Gant T.W., Marczylo T.H. Smoking induces differential miRNA expression in human spermatozoa: a potential transgenerational epigenetic concern?. Epigenetics 2012, 7.
53. Haldar S., Basu A. Modulation of microRNAs by chemical carcinogens and anticancer drugs in human cancer: potential inkling to therapeutic advantage. Mol Cell Pharmacol 2011, 3:135-141.
54. Liu H., D'Andrade P., Fulmer-Smentek S., Lorenzi P., Kohn K.W., Weinstein J.N., et al. mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther 2010, 9:1080-1091.
55. Scott G.K., Mattie M.D., Berger C.E., Benz S.C., Benz C.C. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006, 66:1277-1281.
56. Blower P.E., Chung J.H., Verducci J.S., Lin S., Park J.K., Dai Z., et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008, 7:1-9.
57. Cao Y., Yu S.L., Wang Y., Guo G.Y., Ding Q., An R.H. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 2011, 32:179-188.
58. Bollati V., Marinelli B., Apostoli P., Bonzini M., Nordio F., Hoxha M., et al. Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ Health Perspect 2010, 118:763-768.
59. Pogue A.I., Li Y.Y., Cui J.G., Zhao Y., Kruck T.P., Percy M.E., et al. Characterization of an NF-kappab-regulated, miRNA-146a-mediated down-regulation of complement factor h (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem 2009, 103:1591-1595.
60. Lukiw W.J., Pogue A.I. Induction of specific micro RNA (miRNA) species by ros-generating metal sulfates in primary human brain cells. J Inorg Biochem 2007, 101:1265-1269.
61. Jardim M.J., Fry R.C., Jaspers I., Dailey L., Diaz-Sanchez D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect 2009, 117:1745-1751.
62. Avissar-Whiting M., Veiga K.R., Uhl K.M., Maccani M.A., Gagne L.A., Moen E.L., et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 2010, 29:401-406.
63. Hsu P.Y., Deatherage D.E., Rodriguez B.A., Liyanarachchi S., Weng Y.I., Zuo T., et al. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 2009, 69:5936-5945.
64. Wu X., Song Y. Preferential regulation of miRNA targets by environmental chemicals in the human genome. BMC Genomics 2011, 12:244.
65. Kim D.J., Linnstaedt S., Palma J., Park J.C., Ntrivalas E., Kwak-Kim J.Y., et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 2012, 14:71-80.
66. Bravo V., Rosero S., Ricordi C., Pastori R.L. Instability of miRNA and CDNAs derivatives in RNA preparations. Biochem Biophys Res Commun 2007, 353:1052-1055.
67. Potucek Y., Conrad R. Tips from the bench: stability of miRNA at sub-zero temperatures. Ambion TechNotes Newsl 2007, 14:13.
68. Mraz M., Malinova K., Mayer J., Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 2009, 390:1-4.
69. Grasedieck S., Scholer N., Bommer M., Niess J.H., Tumani H., Rouhi A., et al. Impact of serum storage conditions on microRNA stability. Leukemia 2012, 26:2414-2416.
70. Witwer K.W., Watson A.K., Blankson J.N., Clements J.E. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 2012, 9:5.
71. Rossi R.L., Rossetti G., Wenandy L., Curti S., Ripamonti A., Bonnal R.J., et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA mir-125b. Nat Immunol 2011, 12:796-803.
72. Pritchard C.C., Kroh E., Wood B., Arroyo J.D., Dougherty K.J., Miyaji M.M., et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res 2012, 5:492-497.
73. Kirschner M.B., Kao S.C., Edelman J.J., Armstrong N.J., Vallely M.P., van Zandwijk N., et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 2011, 6:e24145.
74. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006, 5:24.
75. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
76. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
77. Rytting M., Worth L., Jaffe N. Hemolytic disorders associated with cancer. Hematol Oncol Clin North Am 1996, 10:365-376.
78. Petriv O.I., Kuchenbauer F., Delaney A.D., Lecault V., White A., Kent D., et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci USA 2010, 107:15443-15448.
79. Akane A., Matsubara K., Nakamura H., Takahashi S., Kimura K. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci 1994, 39:362-372.
80. Al-Soud W.A., Jonsson L.J., Radstrom P. Identification and characterization of immunoglobulin g in blood as a major inhibitor of diagnostic PCR. J Clin Microbiol 2000, 38:345-350.
81. Al-Soud W.A., Radstrom P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 2001, 39:485-493.
82. Masuda N., Ohnishi T., Kawamoto S., Monden M., Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999, 27:4436-4443.
83. Lewis F., Maughan N.J., Smith V., Hillan K., Quirke P. Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 2001, 195:66-71.
84. Klopfleisch R., Weiss A.T., Gruber A.D. Excavation of a buried treasure-DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol 2011, 26:797-810.
85. Nelson P.T., Baldwin D.A., Scearce L.M., Oberholtzer J.C., Tobias J.W., Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 2004, 1:155-161.
86. Szafranska A.E., Davison T.S., Shingara J., Doleshal M., Riggenbach J.A., Morrison C.D., et al. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 2008, 10:415-423.
87. Xi Y., Nakajima G., Gavin E., Morris C.G., Kudo K., Hayashi K., et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13:1668-1674.
88. Bovell L., Shanmugam C., Katkoori V.R., Zhang B., Vogtmann E., Grizzle W.E., et al. Mirnas are stable in colorectal cancer archival tissue blocks. Front Biosci (Elite Ed) 2012, 4:1937-1940.
89. Arzt L., Kothmaier H., Quehenberger F., Halbwedl I., Wagner K., Maierhofer T., et al. Evaluation of formalin-free tissue fixation for RNA and microRNA studies. Exp Mol Pathol 2011, 91:490-495.
90. Jung M., Schaefer A., Steiner I., Kempkensteffen C., Stephan C., Erbersdobler A., et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 2010, 56:998-1006.
91. Patnaik S.K., Kannisto E., Yendamuri S. Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections. BMC Res Notes 2012, 5:40.
92. Liu A., Tetzlaff M.T., Vanbelle P., Elder D., Feldman M., Tobias J.W., et al. MicroRNA expression profiling outperforms mrna expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol 2009, 2:519-527.
93. Nonn L., Vaishnav A., Gallagher L., Gann P.H. Mrna and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Exp Mol Pathol 2010, 88:45-51.
94. Gregg J.L., Brown K.E., Mintz E.M., Piontkivska H., Fraizer G.C. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection. BMC Cancer 2010, 10:165.
95. Gjerdrum L.M., Abrahamsen H.N., Villegas B., Sorensen B.S., Schmidt H., Hamilton-Dutoit S.J. The influence of immunohistochemistry on mrna recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol 2004, 13:224-233.
96. Schuster C., Budczies J., Faber C., Kirchner T., Hlubek F. MicroRNA expression profiling of specific cells in complex archival tissue stained by immunohistochemistry. Lab Invest 2011, 91:157-165.